全球人口筛检市场规模、份额、趋势和成长分析报告（2026-2034年）

预计人口筛检市场将从 2025 年的 355.8 亿美元成长到 2034 年的 592.5 亿美元，2026 年至 2034 年的复合年增长率为 5.83%。

随着各国政府和医疗机构日益重视疾病早期发现和预防性医疗保健，全球人口筛检市场持续稳定成长。人们对癌症、糖尿病和心血管疾病等慢性病的认识不断提高，推动了大规模筛检计画的需求。许多国家正在投资国家级筛检计划，旨在降低长期医疗成本并提高存活率。诊断工具和数位医疗系统的技术进步也为都市区地区的筛检流程提供了更快、更准确的支援。

文明病和遗传性疾病在全球日益加重，是推动市场成长要素之一。人口老化，尤其是在已开发国家，进一步推动了人们对定期健康检查的需求。医疗服务可近性的提高、保险覆盖范围的扩大以及政府对公共卫生宣传活动的投入，都增强了市场活力。此外，人工智慧和数据分析技术在筛检专案中的应用，正在改善风险评估和个人化医疗，从而提高筛检的有效性和可靠性。

未来几年，随着家用筛检盒和行动医疗设备的推出，市场预计将进一步扩张。新兴经济体随着医疗基础设施的改善，可望迎来强劲的成长机会。数位化平台和远端医疗将使偏远地区的人们更容易获得筛检服务。随着预防医学成为全球优先事项，人群筛检市场将持续创新并维持长期稳定成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球人口筛检市场：依产品划分

• 市场分析、洞察与预测
• 硬体设备（设备、套件、晶片）
• 检测/实验室（服务）
• 分析/解释（个人化和解释）

第五章：全球人口筛检市场：依业务类型划分

• 市场分析、洞察与预测
• 医院
• 研究机构
• 诊断检查室

第六章：全球人口筛检市场：依性别划分

• 市场分析、洞察与预测
• 男性
• 女士

第七章 全球人口筛检市场：按类型划分

• 市场分析、洞察与预测
• 大量的
• 优质的

第八章：全球人口筛检市场：依年龄组别划分

• 市场分析、洞察与预测
• 按年龄
• 15-65岁
• 65岁或以上

第九章 全球人口筛检市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十一章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Quest Diagnostics
  • Illumina Inc
  • ARUP Laboratories
  • Novogene Co. Ltd
  • LGC Limited
  • Gene By Gene Ltd

The Population Screening Market size is expected to reach USD 59.25 Billion in 2034 from USD 35.58 Billion (2025) growing at a CAGR of 5.83% during 2026-2034.

The Global Population Screening Market is growing steadily as governments and healthcare organizations focus more on early disease detection and preventive healthcare. Rising awareness about chronic diseases such as cancer, diabetes, and cardiovascular disorders is driving demand for large-scale screening programs. Many countries are investing in national screening initiatives to reduce long-term healthcare costs and improve survival rates. Technological advancements in diagnostic tools and digital health systems are also supporting faster and more accurate screening processes across urban and rural areas.

One of the main growth drivers is the increasing burden of lifestyle-related and genetic diseases worldwide. Aging populations, especially in developed countries, are further boosting the demand for regular health screening programs. Improved access to healthcare services, expansion of insurance coverage, and government funding for public health campaigns are strengthening the market. Additionally, the integration of AI and data analytics in screening programs is enhancing risk assessment and personalized care, making screening more effective and reliable.

In the coming years, the market is expected to expand further with the adoption of home-based screening kits and mobile health units. Emerging economies are likely to offer strong growth opportunities as healthcare infrastructure improves. Digital platforms and telemedicine will make screening services more accessible to remote populations. As preventive healthcare becomes a global priority, the population screening market is set to witness continuous innovation and long-term sustainable growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Business

• Hospitals
• Research Institutes
• Diagnostic Labs

By Gender

• Male
• Female

By Type

• Mass
• Premium

By Age

• Ages
• 15-65
• Ages 65+

COMPANIES PROFILED

• Agilent Technologies Inc, Thermo Fisher Scientific Inc, QIAGEN, F HoffmannLa Roche Ltd, Quest Diagnostics, Illumina Inc, ARUP Laboratories, Novogene Co Ltd, LGC Limited, Gene by Gene Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POPULATION SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POPULATION SCREENING MARKET: BY BUSINESS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Business
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POPULATION SCREENING MARKET: BY GENDER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Gender
• 6.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POPULATION SCREENING MARKET: BY TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Type
• 7.2. Mass Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Premium Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL POPULATION SCREENING MARKET: BY AGE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Age
• 8.2. Ages
• 8.3. 15-65 Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Ages 65+ Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL POPULATION SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Business
  • 9.2.3 By Gender
  • 9.2.4 By Type
  • 9.2.5 By Age
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Business
  • 9.3.3 By Gender
  • 9.3.4 By Type
  • 9.3.5 By Age
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Business
  • 9.4.3 By Gender
  • 9.4.4 By Type
  • 9.4.5 By Age
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Business
  • 9.5.3 By Gender
  • 9.5.4 By Type
  • 9.5.5 By Age
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Business
  • 9.6.3 By Gender
  • 9.6.4 By Type
  • 9.6.5 By Age
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL POPULATION SCREENING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Thermo Fisher Scientific Inc
  • 11.2.3 QIAGEN
  • 11.2.4 F. Hoffmann-La Roche Ltd
  • 11.2.5 Quest Diagnostics
  • 11.2.6 Illumina Inc
  • 11.2.7 ARUP Laboratories
  • 11.2.8 Novogene Co. Ltd
  • 11.2.9 LGC Limited
  • 11.2.10 Gene By Gene Ltd